Overview Founded more than 50 years ago, the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center has long been at the forefront of research on normal and abnormal brain development. The overarching mission of the Center is to improve the lives of children with intellectual disabilities by fostering basic, translational and clinical research focused on better understanding and treating these conditions. Learn More Make a Gift to the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center Donate Now Research Program Highlights Autism Learn More Research Highlights Learn More IDD Gene Team Learn More Training Learn More IDDRC is structured aroundfour interdisciplinary core programs Human Clinical Phenotyping (HCP) CoreLearn More Neurogenomics (NGEN) CoreLearn More Neural Cell Engineering & Imaging (NCEI) CoreLearn More Animal Phenotyping (AP) CoreLearn More News More News Research Brief Providing Support for Families Affected by Rare Genetic Diseases Mar 15, 2024 Einstein Magazine The Magic of Pediatric Genetics: Q&A With Dr. Melissa Wasserstein Jun 09, 2023 Research Brief Assessing Brain Activity to Predict Dementia Risk Jun 09, 2023 Events More Events 8 January Jan Seminar: Dr. Adam Kepecs Wed Jan 08 2025, 11:00 AM 100 B, Rose F Kennedy Center ian.zeuli@einsteinmed.edu More Dr. Adam Kepecs Washington University Hosted by: Stephanie Rudolph Neuroscience students and post-doctoral fellows are invited to join the speaker after the seminar: Lunch Signup Link Highlights Rose F. Kennedy Center Day - Reveling in the Work of Our Rose F. Kennedy Center Programs and Research On Friday, April 21, 2023, the inaugural Rose F. Kennedy Center Day offered an occasion for celebration, and hope, reflecting on the 50-plus years of the center. Read More | View the Booklet Reducing Ableism in Medicine and Research Recently, NIH designated people with disabilities as a population with health disparities. Read More In the News More Media Coverage When It Comes To the Rarest of Diseases, the Diagnosis Isn't the Answer—It's Just the Starting Point Steven Walkley, D.V.M., Ph.D., and Melissa Wasserstein, M.D., write about the science behind rare diseases and the research and clinical care that Einstein and Montefiore experts provide to families of children with uncommon genetic disorders. Dr. Walkley is co-director of the Rose F. Kennedy Intellectual and Developmental Disabilities Research Center and professor in the Dominick P. Purpura Department of Neuroscience, of pathology, and in the Saul R. Korey Department of Neurology. Dr. Wasserstein is professor of pediatrics and of genetics at Einstein and chief of the division of pediatric genetic medicine at Einstein and Montefiore. Oral Contraception Linked to Smaller Hypothalamus Michael Lipton, M.D., Ph.D., discusses his study, presented as an abstract at the Radiological Society of North America annual meeting, on the association between oral contraception use and the size of the brain’s hypothalamus. Dr. Lipton is professor of radiology and associate director of the Gruss Magnetic Resonance Research Center at Einstein, and director of MRI Services at Montefiore.
